:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ZR5KJD4O5BEITDLWRJNRR5PRL4.jpg?fit=980%2C528&ssl=1 "Arequipa: 18,000 doses of the bivalent vaccine against COVID-19 arrive, Minsa reports | coronavirus in Peru | Ministry of Health | PERU")
The region of Arequipa received the first batch of 18,000 doses of the bivalent vaccine against him COVID-19 to immunize health personnel in a first phase. Then, in the second phase, it will continue with the elderly and people with some comorbidity, reported Constantina Olivares, regional Health manager.
READ MORE | COVID-19: bivalent vaccine will be applied from the second half of January to adults who have four doses
It is reported that the health personnel received 3,000 vials of six doses, which make a total of 18,000 doses of this biological that contains two components. The first that protects from the original virus of COVID-19, and the second of the lineages of the omicron variant that prevails in the world.
Likewise, the Minsa reminded health personnel that to access the new vaccine they must have the fourth dose.
LOOK HERE | Bivalent vaccine in Peru: what is it, how does it work and who is it currently applied to?
It should be noted that Arequipa is the first region to receive the bivalent vaccine after Lima, where 11,593 health professionals have already received the new booster dose against COVID-19.
